These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 4646277
1. The action of L(-)-dopa on baroreflexes in Parkinsonism. Reid JL, Calne DB, George CF, Vakil SD. Clin Sci; 1972 Dec; 43(6):851-9. PubMed ID: 4646277 [No Abstract] [Full Text] [Related]
2. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa. Calne DB, Petrie A, Rao S, Reid JL, Vakil SD. Br J Pharmacol; 1972 Jan; 44(1):162-4. PubMed ID: 5015036 [Abstract] [Full Text] [Related]
8. On the mechanism of L-dopa-induced postural hypotension in the cat. Dhasmana KM, Spilker BA. Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189 [Abstract] [Full Text] [Related]
10. Action of levodopa on the blood pressure of conscious rabbits. Calne DB, Reid JL. Clin Sci; 1973 Apr; 44(4):18P. PubMed ID: 4699305 [No Abstract] [Full Text] [Related]
11. Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor. Pekkarinen A, Rinne UK, Salokangas R, Siirtola T, Sonninen V. Acta Neurol Scand Suppl; 1972 Apr; 51():129-30. PubMed ID: 4514339 [No Abstract] [Full Text] [Related]
13. Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602). Holmsen R, Kvan L, Presthus J, Thoresen GB. Acta Neurol Scand Suppl; 1972 Apr; 51():121-2. PubMed ID: 4514336 [No Abstract] [Full Text] [Related]
14. The effect of various agents on the pressor response to dopa in the anesthetized dog. Pruss TP, McGill JS. Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043 [No Abstract] [Full Text] [Related]
15. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Calne DB, Reid JL, Vakil SD, Rao S, Petrie A, Pallis CA, Gawler J, Thomas PK, Hilson A. Br Med J; 1971 Sep 25; 3(5777):729-32. PubMed ID: 4938431 [Abstract] [Full Text] [Related]
16. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study]. Wälzholz U, Schönfelder H. Nervenarzt; 1972 Oct 25; 43(10):531-2. PubMed ID: 4628192 [No Abstract] [Full Text] [Related]
17. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors. Baldessarini RJ. J Pharm Pharmacol; 1972 Jan 25; 24(1):78-80. PubMed ID: 4401326 [No Abstract] [Full Text] [Related]
18. The effect of L-dopa on postural reflexes in Parkinson's disease. Chaco J, Abramsky O. Z Neurol; 1971 Jan 25; 200(2):122-5. PubMed ID: 4108115 [No Abstract] [Full Text] [Related]
19. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa. Bianchine JR, Messiha FS, Hsu TH. Clin Pharmacol Ther; 1972 Jan 25; 13(4):584-94. PubMed ID: 5042372 [No Abstract] [Full Text] [Related]
20. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor. Klawans HL, Ringel SP, Shenker DM. J Neurol Neurosurg Psychiatry; 1971 Dec 25; 34(6):682-6. PubMed ID: 5158783 [Abstract] [Full Text] [Related] Page: [Next] [New Search]